Scienmag

OCTOBER 21, 2020

Researchers have found that a class of commonly-used heart drugs may also improve patients’ responses to anti-cancer immunotherapies called PD(L)1 inhibitors, according to preliminary findings to be presented at the 32th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics, which is taking place online.

Drugs 73

Drugs Research Clinical Trials Clinical Trials 73

Scienmag

SEPTEMBER 4, 2020

Anticholinergic medications are used for many conditions but might also accelerate cognitive decline, especially in older persons with biological or genetic risk factors A team of scientists, led by researchers at University of California San Diego School of Medicine, report that a class of drugs used for a broad array of conditions, from allergies (..)

Allergies 41

Allergies Drugs Genetics Scientist 41

Scienmag

SEPTEMBER 21, 2020

Researchers say the results have serious implications for the American healthcare system A new study finds middle-aged Americans are now reporting more pain than the elderly — and it has to do with their level of education and that pain is rising more quickly in younger people. Using survey responses from more than 2.5

Research 41

Research Gerontology Drugs Medicine 41

Trialfacts

SEPTEMBER 11, 2023

Researchers need your help to investigate a potential solution. Researchers are looking at the medication metformin as a potential way to help with cognitive decline and possibly prevent Alzheimer’s disease later on. Participants will be helping to advance medical research. Forgetfulness or slight issues in your memory?

Gerontology 52

Gerontology Research Medicine Drugs 52